Add BrightSurf on Google Email

Johns Hopkins Medicine


What doesn't kill the brain makes it stronger

A Johns Hopkins team has identified a newly discovered protein called Iduna that protects the brain against stroke and neurologic disorders. The protein works by interrupting a cascade of molecular events that result in cell death, and its presence increases three- to four-fold in preconditioned mouse brain tissue.

SourceJohns Hopkins Medicine·JournalNature Medicine·DateMay 23, 2011

Gene variation linked to infertility in women, study finds

A study from Johns Hopkins researchers found a link between a gene variation and infertility in women, with the altered gene affecting cholesterol regulation and pregnancy hormone production. The discovery may lead to a treatment for this condition, as a cholesterol medication shown to work in mice could potentially restore fertility.

SourceJohns Hopkins Medicine·JournalHuman Reproduction·DateMay 16, 2011

Blood pressure drug shows some muscle

Researchers discovered losartan improves muscle regeneration and prevents wasting away from inactivity in geriatric mice. The study suggests losartan may have broader clinical applications in protecting against immobilization atrophy in older adults.

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateMay 11, 2011

Adult stem cells take root in livers and repair damage

Researchers at Johns Hopkins Medicine have successfully coaxed adult human cells into an embryonic state and used them to regenerate liver tissue in mice with chronic liver damage. The induced-pluripotent stem cells (iPSCs) showed promise as a potential alternative to liver transplants for patients with serious liver diseases, offering...

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateMay 11, 2011

Animal studies reveal new route to treating heart disease

Researchers found that blocking the action of a signaling protein in cardiac muscle cells halted serious ill effects of high blood pressure on the heart, including enlargement and scar tissue formation. Further tests revealed potential new treatments for heart failure by targeting specific proteins involved in disease progression.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateMay 2, 2011

Hopkins team discovers how DNA changes

Researchers identified a step-by-step process involving TET1 and Apobec1 that converts methylated cytosine into hydroxymethylated cytosine, indicating a potential unified mechanism for DNA methylation status change. The discovery has implications for understanding diseases associated with epigenetic abnormality.

SourceJohns Hopkins Medicine·JournalCell·DateApr 14, 2011

Could HIV-infected organs save lives?

Researchers estimate that lifting the ban on HIV-infected organ donation could provide transplants to 500 patients annually. The study suggests that this change would not only benefit HIV-positive patients but also reduce waiting times for non-HIV infected patients.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Transplantation·DateMar 30, 2011

Computerized systems reduce psychiatric drug errors

Researchers at Johns Hopkins Medicine found that coupling electronic prescription drug ordering systems with computerized adverse event reporting dramatically reduced medication errors in a psychiatric unit from 27.89 to 3.43 per 1,000 patient days over four years. The system's integration of decision support and safety net tools furth...

SourceJohns Hopkins Medicine·JournalJournal of Psychiatric Practice·DateMar 21, 2011

Hopkins researchers use light to move molecules

Researchers at Johns Hopkins Medicine have developed a tool that uses light to move and interact with individual molecules in living cells. This allows for greater control over cellular processes, enabling scientists to study the role of specific proteins and their interactions in cell behavior.

SourceJohns Hopkins Medicine·JournalJournal of the American Chemical Society·DateMar 16, 2011

Insulin-releasing switch discovered

Scientists have identified a protein called Snapin as the molecular switch that controls insulin secretion in pancreatic beta cells. This discovery provides an explanation for the failure of these cells in type 2 diabetes and may lead to new therapies.

SourceJohns Hopkins Medicine·JournalCell Metabolism·DateMar 15, 2011

Solving a traditional Chinese medicine mystery

Researchers at Johns Hopkins Medicine have discovered a natural product from traditional Chinese medicine that blocks gene control machinery in cells, suggesting potential as an anticancer drug. The compound, triptolide, has been shown to be effective against cancer and other conditions.

SourceJohns Hopkins Medicine·JournalNature Chemical Biology·DateMar 3, 2011